SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as analysts raise price targets following a patent extension for IBSRELA and XPHOZAH to 2042, alongside the initiation of a new Phase 3 trial for IBSRELA in Chronic Idiopathic Constipation. The community is actively discussing the company's long-term growth potential and recent earnings, which saw a revenue beat but increased operating expenses to fund significant investments in sales and pipeline expansion.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is actively discussed after announcing a capital raise through a public stock offering and a non-dilutive royalty funding agreement, leading to community debate over the potential dilution versus the strategic financial runway now secured for advancing their prostate cancer drug towards anticipated regulatory submission and other pipeline assets.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is at the center of investor discussion as market participants weigh upcoming critical economic data and a significant Supreme Court tariff ruling, all while navigating heightened geopolitical tensions, sparking widespread debate on market resilience and potential volatility.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending after its NHS-Galleri trial missed a primary endpoint, leading to a sharp decline as bears highlight the perceived failure and cash burn. Conversely, many believe this is an overreaction, citing positive secondary data, substantial cash reserves, existing US market performance, and anticipated FDA approval for the multi-cancer early detection test.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble (RUM) is trending amid escalating short squeeze speculation, fueled by record high short interest and growing strategic investments from Tether, which includes substantial ad and cloud spending commitments and a pivotal acquisition of Northern Data for AI and cloud infrastructure.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending due to positive distribution and sales growth updates from its recent conference and PepsiCo's earnings call, driving bullish community discussions on market expansion; however, some investors express skepticism regarding management and concerns about a potential low-valuation acquisition.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space (FJET) is seeing significant conversation ahead of its NYSE Opening Bell ceremony, amplifying bullish sentiment around its low float and potential for a short squeeze. However, community discussion is sharply divided, with skeptics questioning the company's lack of revenue and direct involvement in recent defense contract news amid broader excitement for the space sector.

Lamar Advertising Co. engages in advertising services. The firm rents advertising space on billboards, buses, shelters, benches, logo plates, and in airport terminals. It operates through the Billboard and Other segments. The company was founded in 1902 and is headquartered in Baton Rouge, LA.

Lamar Advertising Co - Ordinary Shares - Class A

Lamar Advertising (LAMR) is trending following strong Q4 '25 earnings, which showcased impressive GAAP EPS growth and positive revenue figures, coupled with optimistic AFFO guidance for fiscal year 2026. The community is highlighting the company's expanding digital billboard presence, strategic acquisitions, and resilient local advertising demand as key drivers solidifying its position as a compelling outdoor advertising REIT.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is experiencing a surge following its U.S. sBLA response filing for papillary-only disease and a significant European expansion with a major distribution partnership, sparking widespread community discussion about its strong short squeeze potential due to high short interest and the global impact of its Anktiva immunotherapy.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as market participants anticipate an imminent Supreme Court tariff ruling, crucial PCE and GDP data, and escalating geopolitical tensions with Iran. This confluence of events has sharply divided the community, with many expecting continued rallies while others foresee a significant correction, often fueling discussions of market manipulation and underlying structural issues.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ITMPF 

Hydrogen projects become reality

While others are still planning, RWE will soon be supplying green hydrogen. Production at the Lingen plant is scheduled to start next year – a clear signal that these projects are no longer visions of the future.

And $ITMPF  is supplying the electrolyzer, 150 MW

$PLUG $BLDP are beneficiaries of the infrastructure!

Dominik Heim

oldraaa

Thomas Hofmann

sashokd

Elsa Assefa

walter

harryfcg

StockTwits For Android 

ITM Power plc

Plug Power Inc

Ballard Power Systems Inc.

 

Hydrogen projects become reality

While others are still planning, RWE will soon be supplying green hydrogen. Production at the Lingen plant is scheduled to start next year – a clear signal that these projects are no longer visions of the future.

And 